1. 951PA phase Ib study of navicixizumab & weekly paclitaxel in heavily pre-treated platinum resistant ovarian, primary peritoneal or fallopian tube cancer. (23rd October 2018) Authors: Fu, S; Corr, B; Hamilton, E; Burger, R A; Wenham, R; Naumann, R W; Stagg, R; Moore, K N Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗